These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment. Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166 [TBL] [Abstract][Full Text] [Related]
6. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma. Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958 [TBL] [Abstract][Full Text] [Related]
8. Determination of the migration effect and molecular docking of verteporfin in different subtypes of breast cancer cells. Wei C; Li X Mol Med Rep; 2020 Nov; 22(5):3955-3961. PubMed ID: 32901856 [TBL] [Abstract][Full Text] [Related]
9. Verteporfin-loaded microparticles for radiosensitization of preclinical lung and breast metastatic spine cancer. Akinduro OO; Suarez-Meade P; Roberts M; Tzeng SY; Sarabia-Estrada R; Schiapparelli P; Norton ES; Gokaslan ZL; Anastasiadis PZ; Guerrero-Cázares H; Green JJ; Quiñones-Hinojosa A J Neurosurg Spine; 2023 Apr; 38(4):481-493. PubMed ID: 36585863 [TBL] [Abstract][Full Text] [Related]
10. Verteporfin induces apoptosis and reduces the stem cell-like properties in Neuroblastoma tumour-initiating cells through inhibition of the YAP/TAZ pathway. Fusco P; Mattiuzzo E; Frasson C; Viola G; Cimetta E; Esposito MR; Tonini GP Eur J Pharmacol; 2021 Feb; 893():173829. PubMed ID: 33347823 [TBL] [Abstract][Full Text] [Related]
11. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142 [TBL] [Abstract][Full Text] [Related]
13. Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells. Dasari VR; Mazack V; Feng W; Nash J; Carey DJ; Gogoi R Oncotarget; 2017 Apr; 8(17):28628-28640. PubMed ID: 28404908 [TBL] [Abstract][Full Text] [Related]
14. Verteporfin inhibits growth of human glioma in vitro without light activation. Al-Moujahed A; Brodowska K; Stryjewski TP; Efstathiou NE; Vasilikos I; Cichy J; Miller JW; Gragoudas E; Vavvas DG Sci Rep; 2017 Aug; 7(1):7602. PubMed ID: 28790340 [TBL] [Abstract][Full Text] [Related]
15. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation. Wei C; Li X BMC Cancer; 2020 Oct; 20(1):1042. PubMed ID: 33121449 [TBL] [Abstract][Full Text] [Related]
16. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway. Li Y; Yang S; Yang S Cells; 2022 Apr; 11(8):. PubMed ID: 35456040 [TBL] [Abstract][Full Text] [Related]
17. Non-Photoinduced Biological Properties of Verteporfin. Gibault F; Corvaisier M; Bailly F; Huet G; Melnyk P; Cotelle P Curr Med Chem; 2016; 23(11):1171-84. PubMed ID: 26980565 [TBL] [Abstract][Full Text] [Related]
18. Blockage of glioma cell survival by truncated TEAD-binding domain of YAP. Zhao W; Dong QF; Li LW; Yan ZF; Huo JL; Chen XY; Yang X; Li PQ; Fei Z; Zhen HN J Cancer Res Clin Oncol; 2021 Jun; 147(6):1713-1723. PubMed ID: 33651140 [TBL] [Abstract][Full Text] [Related]
19. Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma. Yang J; Wu X; Wang J; Guo X; Chen J; Yang X; Zhong J; Li X; Deng Z Cancer Sci; 2023 May; 114(5):2053-2062. PubMed ID: 36308276 [TBL] [Abstract][Full Text] [Related]
20. Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway. Gibault F; Bailly F; Corvaisier M; Coevoet M; Huet G; Melnyk P; Cotelle P ChemMedChem; 2017 Jun; 12(12):954-961. PubMed ID: 28334506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]